CL2016001165A1 - Proceso preparativo. (divisional sol. n° 3003-2014) - Google Patents

Proceso preparativo. (divisional sol. n° 3003-2014)

Info

Publication number
CL2016001165A1
CL2016001165A1 CL2016001165A CL2016001165A CL2016001165A1 CL 2016001165 A1 CL2016001165 A1 CL 2016001165A1 CL 2016001165 A CL2016001165 A CL 2016001165A CL 2016001165 A CL2016001165 A CL 2016001165A CL 2016001165 A1 CL2016001165 A1 CL 2016001165A1
Authority
CL
Chile
Prior art keywords
triazol
preparatory process
divisional
sol
divisional sol
Prior art date
Application number
CL2016001165A
Other languages
English (en)
Inventor
Hans-Christian Militzer
Johannes Eggert
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48325714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016001165(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of CL2016001165A1 publication Critical patent/CL2016001165A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Abstract

PROCESO DE PREPARACION DE 1H-1,2,3-TRIAZOL-1-IL-ACETATO DE METILO (V-ME) Y 2H-1,2,3-TRIAZOL-1-IL-ACETATO DE METILO (VI-ME) O COMPUESTOS 1H-1,2,3-TRIAZOL-1-IL-ACETATO DE ETILO (V-ET) Y 2H-1,2,3-TRIAZOL-1-IL-ACETATO DE ETILO (VI-ET), QUE COMPRENDE HACER REACCIONAR 1,2,3-TRIAZOL CON BROMOACETATO DE METILO O ETILO EN PRESENCIA DE ETILDIISOPROPILAMINA EN UN DISOLVENTE, A TEMPERATURA ENTRE 20 Y 80°C.
CL2016001165A 2012-05-08 2016-05-13 Proceso preparativo. (divisional sol. n° 3003-2014) CL2016001165A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12167152 2012-05-08

Publications (1)

Publication Number Publication Date
CL2016001165A1 true CL2016001165A1 (es) 2016-12-02

Family

ID=48325714

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2014003003A CL2014003003A1 (es) 2012-05-08 2014-11-06 Proceso para la preparacion de 1-[6-(morfolin—4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1h-pirazol-5-ol (i – forma enol) o de 2-[6-(morfolin-4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1,2-dihidro-3h-pirazol-3-ona (i – forma ceto); y compuesto intermediario (2e/z)-3-(dimetilamino)-2-(1h-1,2,3-triazol-1-il) acrilato de metilo.
CL2016001165A CL2016001165A1 (es) 2012-05-08 2016-05-13 Proceso preparativo. (divisional sol. n° 3003-2014)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2014003003A CL2014003003A1 (es) 2012-05-08 2014-11-06 Proceso para la preparacion de 1-[6-(morfolin—4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1h-pirazol-5-ol (i – forma enol) o de 2-[6-(morfolin-4-il)pirimidin-4-il]-4-(1h-1,2,3-triazol-1-il)-1,2-dihidro-3h-pirazol-3-ona (i – forma ceto); y compuesto intermediario (2e/z)-3-(dimetilamino)-2-(1h-1,2,3-triazol-1-il) acrilato de metilo.

Country Status (36)

Country Link
US (1) US10301289B2 (es)
EP (1) EP2847183B1 (es)
JP (1) JP6149104B2 (es)
KR (1) KR102086389B1 (es)
CN (1) CN104411704B (es)
AP (1) AP2014008089A0 (es)
AU (1) AU2013258107B2 (es)
BR (1) BR112014027564B1 (es)
CA (1) CA2872726C (es)
CL (2) CL2014003003A1 (es)
CO (1) CO7121324A2 (es)
CR (1) CR20140514A (es)
CU (1) CU20140128A7 (es)
DK (1) DK2847183T3 (es)
DO (1) DOP2014000254A (es)
EA (1) EA027804B1 (es)
ES (1) ES2641205T3 (es)
HK (1) HK1208027A1 (es)
HR (1) HRP20171321T1 (es)
HU (1) HUE034430T2 (es)
IL (1) IL235441A (es)
LT (1) LT2847183T (es)
MX (1) MX350519B (es)
MY (1) MY184577A (es)
NZ (1) NZ701661A (es)
PE (1) PE20142453A1 (es)
PH (1) PH12014502482A1 (es)
PL (1) PL2847183T3 (es)
PT (1) PT2847183T (es)
RS (1) RS56255B1 (es)
SG (2) SG10201609319YA (es)
SI (1) SI2847183T1 (es)
TN (1) TN2014000469A1 (es)
UA (1) UA116349C2 (es)
WO (1) WO2013167552A1 (es)
ZA (1) ZA201408571B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY37222A (es) * 2016-05-03 2017-11-30 Bayer Pharma AG PROCEDIMIENTO PARA LA PREPARACIÓN DE DERIVADOS DE 1-FENILO-1,2,4-TRIAZOL SUSTITUIDOS POR 5-HIdroxIalQUILO
CN108084099B (zh) * 2017-12-20 2019-01-29 天驰药业有限公司 一种1,2,3-三氮唑化合物的合成方法
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents
EP3888684A1 (en) 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition having improved voluntary acceptance
CN114264752B (zh) * 2021-12-29 2023-08-15 北京金城泰尔制药有限公司 溴乙酸甲酯的检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135184A (da) 1983-03-03 1984-10-10 Riker Laboratories Inc Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4752910A (en) 1984-10-30 1988-06-21 Prime Computer, Inc. Method and apparatus for continuous after-imaging
UY27813A1 (es) 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
TWI335913B (en) 2002-11-15 2011-01-11 Vertex Pharma Diaminotriazoles useful as inhibitors of protein kinases
WO2005044785A1 (en) * 2003-10-30 2005-05-19 Merck & Co., Inc. Aralkyl amines as cannabinoid receptor modulators
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
DE102008020113A1 (de) 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituierte Dihydropyrazolone und ihre Verwendung
EP1877399A1 (en) 2005-04-26 2008-01-16 Pfizer Limited Triazole derivatives as vasopressin antagonists
US20080234252A1 (en) 2005-05-18 2008-09-25 Pfizer Inc Compounds Useful in Therapy
DE102006050516A1 (de) * 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dihydropyrazolone und ihre Verwendung
DE102010041236A1 (de) * 2010-09-23 2012-03-29 Osram Ag Optoelektronisches Halbleiterbauelement
DE102010044131A1 (de) * 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat

Also Published As

Publication number Publication date
ES2641205T3 (es) 2017-11-08
LT2847183T (lt) 2017-09-25
CA2872726A1 (en) 2013-11-14
PE20142453A1 (es) 2015-01-17
MY184577A (en) 2021-04-06
CR20140514A (es) 2014-12-02
UA116349C2 (uk) 2018-03-12
BR112014027564B1 (pt) 2022-05-03
CA2872726C (en) 2020-07-07
CN104411704B (zh) 2017-12-22
JP6149104B2 (ja) 2017-06-14
CN104411704A (zh) 2015-03-11
PH12014502482A1 (en) 2015-01-12
EA201492032A1 (ru) 2015-04-30
NZ701661A (en) 2016-08-26
AP2014008089A0 (en) 2014-11-30
US10301289B2 (en) 2019-05-28
JP2015516403A (ja) 2015-06-11
MX2014013448A (es) 2014-12-08
PT2847183T (pt) 2017-10-02
KR102086389B1 (ko) 2020-03-09
HUE034430T2 (en) 2018-02-28
HK1208027A1 (en) 2016-02-19
IL235441A (en) 2017-09-28
AU2013258107A1 (en) 2014-11-27
SG10201609319YA (en) 2016-12-29
KR20150018534A (ko) 2015-02-23
SI2847183T1 (sl) 2017-10-30
BR112014027564A2 (es) 2017-08-22
TN2014000469A1 (en) 2016-03-30
WO2013167552A1 (de) 2013-11-14
DOP2014000254A (es) 2016-01-31
EP2847183B1 (de) 2017-06-21
ZA201408571B (en) 2016-03-30
EA027804B1 (ru) 2017-09-29
AU2013258107B2 (en) 2017-06-22
DK2847183T3 (en) 2017-10-02
PL2847183T3 (pl) 2017-11-30
CO7121324A2 (es) 2014-11-20
EP2847183A1 (de) 2015-03-18
RS56255B1 (sr) 2017-11-30
HRP20171321T1 (hr) 2017-10-20
CU20140128A7 (es) 2015-03-30
CL2014003003A1 (es) 2015-02-13
SG11201407043PA (en) 2014-12-30
MX350519B (es) 2017-09-08
US20150087827A1 (en) 2015-03-26

Similar Documents

Publication Publication Date Title
CL2016001165A1 (es) Proceso preparativo. (divisional sol. n° 3003-2014)
PH12014502169A1 (en) N-cyclylamides as nematicides
NZ734919A (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
PH12015502814A1 (en) 4-membered ring carboxamides used as nematicides
WO2014025719A3 (en) Test specimen holder for high temperature environments
UY33397A (es) Forma sólida de un naftaleno carboxamida
MY191601A (en) Compositions comprising anti-cd38 antibodies and lenalidomide
EP2566859A4 (en) PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
NZ726521A (en) Pesticidal compositions and processes related thereto
UA103625C2 (en) 5-hetrocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enons as herbicides
EP2822998A4 (en) COMPATIBILIZED COMPOSITION, METHOD FOR FORMING THE SAME, AND ARTICLE COMPRISING SAME
NZ731103A (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
WO2014197197A8 (en) High temperature geomembrane liners and master batch compositions
CA2879720A1 (en) Apparatus, systems, and methods for performing thermal melt analyses and amplifications
NZ726907A (en) Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
CL2013002971A1 (es) Compuestos derivados de 5-(fenil/piridinil-etinil)-2-piridina/2-pirimidina-carboxamida, moduladores mglur5; composición farmacéutica que los comprende; proceso de preparación de ellos; y su uso en el tratamiento de esquizofrenia o enfermedades cognitivas.
PH12015501054A1 (en) Pyridiyloxyalkyl carboxamides and use thereof as endoparasiticides and nematicides
NZ739853A (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
EP2836551A4 (en) COMPATIBILIZED COMPOSITION, PROCESS FOR FORMATION THEREOF, AND ARTICLE COMPRISING SAME
MX2016001641A (es) Ciclobutilcarboxamidas como nematicidas.
WO2015134599A3 (en) Platinum(iv) compounds and methods of making and using same
WO2013184570A3 (en) Synthesis of 1,3-substituted aminouracils and other xanthine-related compounds
MX2016005220A (es) Tinturas acidas, proceso para su produccion y su uso.
IT1400702B1 (it) Apparecchiatura per l'imballaggio di carichi con pellicola termoretraibile, dotata di bruciatori regolabili.
TH148347B (th) "ส่วนประกอบสารต้านอนุมูลอิสระที่มีปริมาณแคลอรีต่ำ, กระบวนการได้สิ่งดังกล่าวมา และการใช้สิ่งดังกล่าว"